NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson, with support from the Johnson & Johnson (J&J) Foundation, announced that it has donated $100 million of MedTech products since 2020 to help mor
CIBC Asset Management Inc decreased its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 3.6% during the undefined quarter, according to its most recent 13F filing with the Securities and Exch
The current macro investing climate is one in which investors have plenty to consider.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Envestnet Portfolio Solutions Inc. lowered its position in Johnson and Johnson (NYSE: JNJ) by 10.5% in the undefined quarter, according to the company in its most recent Form 13F filing with the Secur
Deseret Mutual Benefit Administrators raised its stake in shares of Johnson and Johnson (NYSE: JNJ) by 27.7% in the third quarter, according to its most recent filing with the Securities and Exchange
Birch Financial Group LLC raised its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 127.1% during the third quarter, according to the company in its most recent disclosure with the Securitie
BIP Wealth LLC increased its stake in shares of Johnson and Johnson (NYSE: JNJ) by 55.4% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Ex
JNJ beat Q4 earnings and sales estimates and sees 2026 free cash flow rising to $21B, making healthcare ETFs a safer way to play its momentum.

2 Soaring Stocks to Hold for the Next 20 Years

12:30pm, Friday, 23'rd Jan 2026
These companies have resilient businesses that can navigate challenges. Both are great dividend-paying stocks.
Johnson & Johnson NYSE: JNJ, amid the noise of Trump's Greenland agenda and renewed trade war fears, is quietly executing its healthcare strategy, growing revenue and widening margins, setting its sto
Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest U.S.

Is This Dividend King a Screaming Buy?

04:44am, Friday, 23'rd Jan 2026
Johnson & Johnson has increased its dividend for an impressive 63 consecutive years. The company appears to be navigating an expanding patent cliff well.

Johnson & Johnson Q4 Earnings Call Highlights

01:02am, Friday, 23'rd Jan 2026
Johnson and Johnson (NYSE: JNJ) executives highlighted what they described as a "catapult year" in 2025, pointing to strong operational sales growth, accelerating momentum in key therapeutic and devic
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE